David Hallal - 21 Apr 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Director, 10%+ Owner
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
ALVR
Transactions as of
21 Apr 2022
Transactions value $
$-24,812
Form type
4
Filing time
22 Apr 2022, 08:31:45 UTC
Previous filing
11 Mar 2022
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $-24,812 -4,227 -0.2% $5.87 2,143,614 21 Apr 2022 Direct F1
holding ALVR Common Stock 13,420,970 21 Apr 2022 See Footnote F2
holding ALVR Common Stock 1,120,965 21 Apr 2022 See Footnote F3
holding ALVR Common Stock 738,153 21 Apr 2022 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 7, 2022 to cover tax withholding obligations upon the vesting and settlement of restricted stock units.
F2 Shares held by ElevateBio LLC ("ElevateBio"). The Reporting Person is the Chairman and Chief Executive Officer of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 Shares held by The Hallal Family Irrevocable Trust 2012, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 Shares held by Terrie A. Hallal Family Irrevocable Trust 2012, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.